CompletedPhase 1NCT03604679

SyB C-0501(Oral Bendamustine) in Patients With Advanced Solid Tumors

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
SymBio Pharmaceuticals
Principal Investigator
Katsuhisa Goto
SymBio Pharmaceuticals
Intervention
SyB C-0501(drug)
Enrollment
18 enrolled
Eligibility
20 years · All sexes
Timeline
20182020

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03604679 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials